← brief for 2026-10-21 · People & money

Availability of age-stratified evidence for GLP1 receptor agonists and SGLT2 inhibitors: an analysis of European public assessment reports with a focus on older patients

Article C Peer reviewed Observational

Key takeaways

This review looked at 185 trials of common diabetes drugs. It found that older adults are often left out of these studies. It shows a gap in the data, not a new treatment result.

Who did this work

Svea Stüdemann (Universitätsmedizin Greifswald) · Maik Gollasch (Universitätsmedizin Greifswald) · Stefan Engeli (Universitätsmedizin Greifswald)

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-20
https://doi.org/10.3389/fphar.2026.1786211